A primer on the treatment of schizophrenia through repetitive transcranial magnetic stimulation

References

• Barker A, Jalinous R, Freeston I. Non-invasive magnetic stimulation of the human motor cortex. Lancet 325(8437), 1106–1107 (1985).
   Google Scholar
• Fregni F, Marcolin M, Myczkowski M et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 9, 641–654 (2006).
   PubMed Web of Science ®Google Scholar
• George M, Lisanby S, Avery D et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch. Gen. Psychiatry 67(5), 507–516 (2010).
   PubMed Web of Science ®Google Scholar
• Hovington C, Lepage M. Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia. Expert Rev. Neurother. 12, 53–69 (2012).
   PubMed Web of Science ®Google Scholar
• Murphy B, Chung Y, Park T, Mcgorry P. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr. Res. 88, 5–25 (2006).
   PubMed Web of Science ®Google Scholar
• Dlabac-De-Lange J, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J. Clin. Psychiatry 71, 411–419 (2010).
   PubMedGoogle Scholar
• Slotema CW, Aleman A, Daskalakis ZJ, Sommer IE. Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr. Res. 142(1–3), 40–45 (2012).
   PubMedGoogle Scholar
• Fitzgerald P, Brown T, Daskalakis Z. The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr. Scand. 105, 324–340 (2002).
   PubMed Web of Science ®Google Scholar
• Marangell L, Martinez M, Jurdi R, Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr. Scand. 116(19), 174–181 (2007).
   PubMedGoogle Scholar
• Goyal N, Nizamie S, Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. J. Neuropsychiatry Clin. Neurosci. 19, 464–467 (2007).
   PubMed Web of Science ®Google Scholar
• Andreasen N, Flaum M. Schizophrenia: the characteristic symptoms. Schizophr. Bull. 17, 27–49 (1991).
   PubMed Web of Science ®Google Scholar
• Pantelis C, Lambert T. Managing patients with “treatment-resistant” schizophrenia. Med. J. Aust. 178(9), 62–66 (2003).
   Google Scholar
• Shergill SS, Murray RM, Mcguire PK. Auditory hallucinations: a review of psychological treatments. Schizophr. Res. 32(3), 137–150 (1998).
   PubMed Web of Science ®Google Scholar
• Silbersweig DA, Stern E, Frith C et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 378(6553), 176–179 (1995).
   PubMed Web of Science ®Google Scholar
• Hoffman R, Boutros R, Berman R et al. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biol.Psychiatry 46, 130–132 (1999).
   PubMed Web of Science ®Google Scholar
• Hoffman R, Hawkins K, Gueorguieva R et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch. Gen. Psychiatry 60, 49–56 (2003).
   PubMed Web of Science ®Google Scholar
• Blumberger DM, Christensen BK, Zipursky RB et al. MRI-targeted repetitive transcranial magnetic stimulation of Heschl’s gyrus for refractory auditory hallucinations. Brain Stimul. 5(4), 577–585 (2012).
   PubMed Web of Science ®Google Scholar
• Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J. Clin. Psychiatry 68(3), 416–421 (2007).
   PubMed Web of Science ®Google Scholar
• Koutsouleris N, Gaser C, Jager M et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. NeuroImage 39, 1600–1612 (2008).
   PubMed Web of Science ®Google Scholar
• Quarantelli M, Larobina M, Volpe U et al. Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia. NeuroImage 17, 373–384 (2002).
   PubMedGoogle Scholar
• Yoshida T, Mccarley R, Nakamura M et al. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr. Res. 113, 84–94 (2009).
   PubMed Web of Science ®Google Scholar
• Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand. 110(4), 243–256 (2004).
   PubMedGoogle Scholar
• Stoeber G, Ben-Shachar D, Cardon M et al. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J. Biol. Psychiatry 10, 127–155 (2009).
   PubMedGoogle Scholar
• Weinberger D, Egan M, Abertolino et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 50, 825–844 (2001).
   PubMed Web of Science ®Google Scholar
• cual-Leone A, Tormos JM, Keenan J, Tarazona F, Cañete C, Catalá MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J. Clin. Neurophysiol. 15, 333–343 (1998).
   PubMedGoogle Scholar
• Conca A, Peschina W, König P, Fritzsche H, Hausmann A. Effect of chronic repetitive Transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment resistant depressives: a brief report. Neuropsychobiology 45, 27–31 (2002).
   PubMedGoogle Scholar
• Fox P, Ingham R, George M et al. Imaging human intra-cerebral connectivity by PET during TMS. Neuroreport 8, 2787–2791 (1997).
   PubMedGoogle Scholar
• Mottaghy F, Keller C, Gangitano M et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res. 115, 1–14 (2002).
   PubMed Web of Science ®Google Scholar
• Cohen E, Bernardo M, Masana J et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J. Neurol. Neurosurg. Psychiatry 67, 129–130 (1999).
   PubMed Web of Science ®Google Scholar
• Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch. Gen. Psychiatry 49, 959–965. (1992).
   PubMed Web of Science ®Google Scholar
• Sabri O, Erkwoh R, Schreckenberger M et al. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naïve schizophrenics. J. Nucl. Med. 8, 181–188 (1997).
   Google Scholar
• Fitzgerald PB, Herring S, Hoy K et al. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul. 1(1), 27–32 (2008).
   PubMed Web of Science ®Google Scholar
• Barr MS, Farzan F, Tran LC, Fitzgerald PB, Daskalakis ZJ. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimul. 5(3), 337–346 (2012).
   PubMed Web of Science ®Google Scholar
• Jin Y, Potkin S, Kemp A et al. Therapeutic effects of individualized frequency transcranial magnetic stimulation (rTMS) on the negative symptoms of schizophrenia. Schizophr. Bull. 32, 556–561 (2006).
   PubMed Web of Science ®Google Scholar
• Jockers-Scherübl MC, Bauer A, Godemann F, Reischies FM, Selig F, Schlattmann P. Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study. Int. Clin. Psychopharmacol. 20, 27–31 (2005).
   PubMed Web of Science ®Google Scholar
• Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153(3), 321–330 (1996).
   PubMed Web of Science ®Google Scholar
• Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J. Clin. Psychiatry 67(Suppl. 9), 3–8, discussion 36–42 (2006).
   PubMedGoogle Scholar
• Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 72(1), 41–51 (2004).
   PubMed Web of Science ®Google Scholar
• Forbes NF, Carrick LA, Mcintosh AM, Lawrie SM. Working memory in schizophrenia: a meta-analysis. Psychol. Med.39(6), 889–905 (2009).
   PubMed Web of Science ®Google Scholar
• Callicott JH, Bertolino A, Mattay VS et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex 10(11), 1078–1092 (2000).
   PubMedGoogle Scholar
• Manoach DS, Gollub RL, Benson ES et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol. Psychiatry 48(2), 99–109 (2000).
   PubMed Web of Science ®Google Scholar
• Barch DM, Csernansky JG, Conturo T, Snyder AZ. Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? J. Abnorm. Psychol. 111(3), 478–494 (2002).
   PubMedGoogle Scholar
• Preston G, Anderson E, Silva C, Goldberg T, Wassermann EM. Effects of 10 Hz rTMS on the neural efficiency of working memory. J. Cogn. Neurosci. 22(3), 447–456 (2010).
   PubMedGoogle Scholar
• Hamidi M, Tononi G, Postle BR. Evaluating the role of prefrontal and parietal cortices in memory-guided response with repetitive transcranial magnetic stimulation. Neuropsychologia 47(2), 295–302 (2009).
   PubMedGoogle Scholar
• Barr MS, Farzan F, Rajji TK et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol. Psychiatry 73(6), 510–517 (2013).
   PubMedGoogle Scholar
• Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr. Res. 108, 11–24 (2009).
   PubMed Web of Science ®Google Scholar
• Andreasen N, Nopoulos P, O’leary D, Miller D, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol.Psychiatry 46, 908–920 (1999).
   PubMed Web of Science ®Google Scholar
• Liang M, Zhou Y, Jiang T et al. Widespread functional disconnectivity in schizophrenia with resting-state functional magnetic resonance imaging. Neuroreport 17, 209–213 (2006).
   PubMed Web of Science ®Google Scholar
• Stephan K, Friston K, Frith C. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull. 35, 509–527 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liang M, Tian L et al. Functional disintegration in paranoid schizophrenia using resting-state fMRI. Schizophr. Res.97, 194–205 (2007).
   PubMed Web of Science ®Google Scholar
• Barrett J, La-Maggiore V, Chouinard P, Paus T. Mechanisms of action underlying the effect of repetitive transcranial magnetic stimulation on mood: behavioral and brain imaging studies. Neuropsychopharmacology 29, 1172–1189 (2004).
   PubMedGoogle Scholar
• Paus T, Jech R, Thompson C, Comeau R, Peters T, Evans A. Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. J. Neurosci. 17, 3178–3184 (1997).
   PubMed Web of Science ®Google Scholar
• Prikryl R, Ustohal L, Kucerova HP, Cermakova I, Ceskova E. Effect of sequential frontotemporal repetitive transcranial magnetic stimulation (rTMS) on schizophrenia. Activitas. Nervosa. Superior Rediviva. 1, 37–41 (2010).
   Google Scholar